Bafna Pharmaceuticals Ltd Annually Results

Gross Sales

43.36

47.17

64.96

85.32

97.67

Excise Duty

0

0

0

0

0

Net Sales

43.36

47.17

64.96

85.32

97.67

Other Operating Income

0

0

0

0

41.11

Other Income

1.66

31.33

1.14

1.98

4.9

Total Income

45.02

78.5

66.1

87.3

143.68

Total Expenditure

56.7

82.3

70.77

84.8

118.17

PBIDT

-11.68

-3.8

-4.67

2.5

25.51

Interest

2.13

6.94

11.47

12.96

13.46

PBDT

-13.81

-10.74

-16.14

-10.46

12.05

Depreciation

3.48

3.97

4.22

4.86

5.99

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

-0.15

Deferred Tax

1.07

2.19

-0.9

-0.18

0

Reported Profit After Tax

-18.35

-16.91

-19.46

-15.14

6.22

Minority Interest After NP

0

0

0

-1.11

0.04

Net Profit after Minority Interest

-18.35

-16.91

-19.46

-14.03

6.18

Extra-ordinary Items

0.95

0

0

0

-2.83

Adjusted Profit After Extra-ordinary item

-19.3

-16.91

-19.46

-14.03

9.01

EPS (Unit Curr.)

-11.44

-0.11

-11.98

-8.8

3.57

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

23.66

23.66

18.66

18.66

18.66

Public Shareholding (Number)

0

0

0

0

1,18,05,566

Public Shareholding (%)

0

0

0

0

63.28

Pledged/Encumbered - No. of Shares

0

0

0

0

13,97,736

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

20.4

Pledged/Encumbered - % in Total Equity

0

0

0

0

7.49

Non Encumbered - No. of Shares

0

0

0

0

54,53,033

Non Encumbered - % in Total Promoters Holding

0

0

0

0

79.6

Non Encumbered - % in Total Equity

0

0

0

0

29.23

PBIDTM(%)

-26.93

-8.05

-7.18

2.93

26.11

PBDTM(%)

-31.84

-22.76

-24.84

-12.25

12.33

PATM(%)

-42.32

-35.84

-29.95

-17.74

6.36